Douglas Elliman Declares Quarterly Cash Dividend
Get Alerts DOUG Hot Sheet
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- Douglas Elliman Inc. (NYSE: DOUG) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.05 per share. The quarterly cash dividend will be payable on June 29, 2022 to holders of record as of June 17, 2022.
About Douglas Elliman Inc.
Douglas Elliman Inc. (NYSE: DOUG, “Douglas Elliman”) owns Douglas Elliman Realty, LLC, which is one of the largest residential brokerage companies in the United States with operations in New York City, Long Island, Westchester, Connecticut, New Jersey, the Hamptons, Massachusetts, Florida, California, Colorado, Texas and Nevada. In addition, Douglas Elliman sources, uses and invests in early-stage, disruptive property technology (“PropTech”) solutions and companies and provides other real estate services, including development marketing, property management and settlement and escrow services in select markets. Additional information concerning Douglas Elliman is available on its website, www.elliman.com.
Investors and others should note that we may post information about Douglas Elliman on our website at www.elliman.com or, if applicable, on our accounts on Facebook, Instagram, LinkedIn, TikTok, Twitter, YouTube or other social media platforms. It is possible that the postings or releases could include information deemed to be material information. Therefore, we encourage investors, the media and others interested in Douglas Elliman to review the information we post on our website at www.elliman.com and on our social media accounts.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005975/en/
Emily Claffey/Benjamin Spicehandler
Sard Verbinnen & Co
212-687-8080
Source: Douglas Elliman Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- More Than 100 Retired California Judges Create “Wall of Justice” to Defend the Rule of Law & An Independent Judiciary
- Lytho Launches AI Expert Reviewers, Embedding Instant Brand and Regulatory Compliance into Enterprise Content Workflows
- AL-S Pharma Presents AP-101 Phase 2 Data Supporting Misfolded SOD1 as a Therapeutic Target in ALS at ENCALS 2026
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Twitter, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share